A costly new medication for a rare blood clotting condition has just been
approved by the Federal Drug Administration (FDA) in the United States.
It will be the most costly medication globally, costing US$3.5 million for
each dose.
Although the price seems outrageous initially, a recent examination of the
drug’s cost-effectiveness reveals that it is, at least in the US, a
somewhat “fair” price for the treatment’s results.
approved by the Federal Drug Administration (FDA) in the United States.
It will be the most costly medication globally, costing US$3.5 million for
each dose.
Although the price seems outrageous initially, a recent examination of the
drug’s cost-effectiveness reveals that it is, at least in the US, a
somewhat “fair” price for the treatment’s results.
